8 comments
36 forecasters
Will tirzepatide be approved for the treatment of obesity by the FDA or EMA before 2025?
80%chance
ResolvedYes
The community gave this a 80% chance, and it resolved Yes.
Forecast Timeline
Authors:
Opened:Nov 24, 2021
Closes:Dec 31, 2024
Resolved:Nov 8, 2023
Spot Scoring Time:Nov 26, 2021
Learn more about Metaculus NewsMatch
Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?
47% chance
27
Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?
83% chance
47
Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?
74% chance
44